Contracts › 75N95025F00001
75N95025F00001: Investigational Agent Single Ascending Dose Safety, Tolerability, and Pk Study. Pop: 5/2/2025 - 11/1/2026. N01DA-23-8935
Awarded to Altasciences Clinical Kansas Inc by National Institutes of Health (NIH).
$1.6Mobligated
$1.6Mpotential value
01 November 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N95025F00001 |
|---|---|
| Vehicle | 75N95023D00019 |
| Awardee | Altasciences Clinical Kansas Inc |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | KS |
| Period of performance | 02 May 2025 to 01 November 2026 |
| Potential end | 01 November 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record